
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Incorporated in 2002, Brooks Laboratories Ltd is in the business of Pharmaceutical Contract Research & Manufacturing. Company manufactures wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.Brooks Labs has manufacturing unit at Baddi, Himachal Pradesh. Company has a world class team to develop new molecules in injectables and clavulanic acid based products supported by sophisticated infrastructure for Research & Development. Brooks Labs is WHO-GMP and ISO 9000-2008 certified company.The Indian pharmaceuticals industry is significantly developed in terms of infrastructure, technology and product range in recent years. The country now ranks among the top four worldwide accounting for 8% to 10% of world’s production by volume and 1.5% to 2% by value.

						
						
							
						
						

						Company Promoters:The promoters of the company are:1 Mr. Atul Ranchal2 Mr. Rajesh Mahajan

						Company Financials:
   ParticularsFor the year/period ended (in Rs. Lacs)
   31-Mar-1131-Mar-1031-Mar-0931-Mar-0831-Mar-07
     Total Income5319.94545.34383.22854.22381.3
     Profit After Tax (PAT)688.82519.57296.06358.01112.49
  

						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The objects of the Issue are:1. To set up our new manufacturing unit at JB SEZ Pvt Ltd, Panoli, Gujarat for manufacturing of various pharmaceuticals formulations.2. To meet Long Term Working Capital requirement.3. To meet General Corporate Purpose and4. To meet Issue Expenses and Listing of Shares on Stock Exchanges.

						Issue Detail:
						Â Â Â»Â»Â Â Issue Open: Aug 16, 2011 - Aug 18, 2011
							Â Â Â»Â»Â Â Issue Type: Book Built Issue IPO
							Â Â Â»Â»Â Â Issue Size: 6,300,000 Equity Shares of Rs 10 aggregating up to Rs 63.00 Cr
							
							
							Â Â Â»Â»Â Â Face Value: Rs 10 Per Equity Share
							Â Â Â»Â»Â Â Issue Price: Rs. 90 - Rs. 100 Per Equity Share
							Â Â Â»Â»Â Â Market Lot: 60 Shares
							Â Â Â»Â»Â Â Minimum Order Quantity: 60 Shares
							Â Â Â»Â»Â Â Listing At: BSE, NSE
						

						Brooks Laboratories IPO Grading

ICRA has assigned an IPO Grade 2 to Brooks Laboratories IPO. This means as per ICRA, company has 'Below Average Fundamentals'. ICRA assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Read Brooks Laboratories IPO Report

Check IPO Ratings from other stock analysts.


						
						Brooks Labs IPO Reviews:
						
							
							Brooks Laboratories Ltd IPO review by MLR Securities Private Ltd
							
						
						


						
							
						

						
							Issue Subscription Detail / Current Bidding StatusNumber of Times Issue is Subscribed (BSE + NSE)As on Date & TimeQIBNIIRIITotalShares Offered / Reserved3,500,0001,050,0002,450,0007,000,000Day 1 - Aug 16, 2011 17:00 IST0.00000.08000.19000.0800Day 2 - Aug 17, 2011 17:00 IST0.00000.33000.61000.2600Day 3 - Aug 18, 2011 17:00 IST0.00002.82003.36001.6000
						
					
